The current study deals with the development of floating microspheres of venlafaxine hydrochloride. This drug is known as a serotonin-norepinephrine reuptake inhibitor and used to treat depression. Due to the short elimination half life of 4-5 h, the drug has to be administred 2-3 times in a day to maintain the plasma concentration. Thus an attempt was made to decrease the dosing frequency. The microspheres were prepared by non-aqueous solvent evaporation method. The microspheres were evaluated for particle size and morphology using a photomicroscope and scanning electron microscopy, respectively. The incorporation efficiency of microspheres of batch F2 and F6 showed entrapment of 60.6% and 57.2%, respectively. The mean diameters of particles for all batches were found in the range of 226.15 ± 24.37 to 283.37 ± 21.56 µm. The Fourier transform infrared spectroscopy revealed absence of any drugpolymer interactions. The microsphers remained buoyant for more than 12 h. The drug release from developed microspheres followed Fickian diffusion with swelling. The results suggested that the developed floating microspheres containing venlafaxine hydrochloride could enhance drug entrapment efficiency, reduce the initial burst release and modulate the drug release.
has emerged as one of the best controlled drug delivery system, which delivers the drugs in a controlled rate over a period of time [5] .
Venlafaxine hydrochloride, is a highly water soluble and structurally novel antidepressant for oral administration. It is a dual serotonin and norepinephrine reuptake inhibitor [6] . It inhibits the serotonin transporter at 30 fold lower concentrations than norepinephrine transporter, respectively. It display differential effects on norepinephrine reuptake in healthy versus depressed patients [7] . It is highly soluble in 0.1 N HCl and it decreases with increasing pH over the physiological range. The half-life of venlafaxine hydrochloride is 5 ± 2 h, necessitating the administration, two or three times daily to maintain adequate plasma drug concentration [8] .
Response surface methodology (RSM) is a group of mathematical and statistical techniques which plays an important role in experimental design. The objective of RSM is to optimize the response of various independant variables. RSM has applications in the situations where several input variables (indepandant variables) potentially influence some performance measure or quality characteristic (depandant variables) of the process. Thus, performance measure or quality characteristic is called the response [10] . The purpose of this study was to improve the release profile of velnafexine HCl in the stomach in a controlled manner to improve the therapeutic benefit of selected drug. It is hypothesized the improved bioavailability might be due to increased surface area and swelling and hydration nature of polymers used.
RESULTS AND DISCUSSION

Fourier Transform Infrared (FTIR) Spectroscopy
The results of FTIR studies of venlafaxine HCl and drug loaded microspheres (formulation F2) to determine interactions and structural changes in drug and excipients are shown in Figure 1 . The FTIR spectrum of venlafaxine HCl exhibited peaks at 3321 cm -1 assigned to symmetric stretching peaks of -OH, 2943 cm -1 (aliphatic CH stretching), 1514 cm -1 (stretching of C6H5), 1039 cm -1 (C-O-C stretching). Characteristic peaks of drug were also present in FTIR spectrum of microspheres. Some peaks were shifted with a very slight change in the wave number. These results suggested that there was no interaction between venlafaxine HCl and excipients. 
Percentage yield
The maximum percentage yield was found to be for batch F2 and minimum of 77.45% for batch F7 (Table 1) .
Particle size and bulk density of microspheres
The analysis was performed for all eight batches by photomicroscope using micrometric tools. The results were as shown in table 1. The mean diameters of particles for all batches were found in the range of 226.15±24.37 to 283.37±21.56 µm. The bulk density determination was performed for all eight batches. The bulk densities for all samples were found to be in the range of 0.75±0.02 mg/ml to 0.82±0.03 mg/ml, respectively. Tapped density was in the range of 0.88±0.02 mg/ml to 0.99±0.07 mg/ml. the difference in bulk density was small, which confirms small and uniform particle size. 
Buoyancy percentage
The purpose of preparing floating microspheres was to extend the gastric residence time of the drug. The buoyancy test was carried out to investigate the floatability of the prepared microspheres. The particles were spread over the surface of a simulated gastric fluid and the fraction of microspheres settled down as a function of time was quantitated. The fraction of floating microspheres reduced up to 12 h suggesting that the absorption of the drug in vivo pertaining to sustained release would be linear with time ( Table 2 ). As the time passed, water gradually entered into the microspheres and subsequently the density was increased and microspheres sink to the bottom. The sinking was observed maximum in formulation containing gum at highest concentration. Buoyancy of batch F2 was found to be 76 %, which indicate that most of the microspheres were floatable. 
Drug entrapment efficiency
The microspheres of batch F2 and F6 showed entrapment of 60.6% and 57.2%, respectively while least entrapment was observed in F1 and F4 particles were least entrapped (Table 1) . It attributed to the permeation characteristics of each polymer [16] .
Surface morphology
Detailed observation of morphological characters of the dried microspheres (Formulation F2.) was done by SEM. The SEM photomicrographs confirmed the spherical shape with rough surface of the microspheres ( Figure 2 ). The results showed that the polymer type had significant effect on morphology of beads. 
In-vitro dissolution studies
In vitro drug release profiles showed that the polymer combination had excellent control on the release of the drug from microspheres in gastric fluid (figure 3) [17] . An attempt was made to control the drug release by use of polymer combination. The results of in vitro drug release study showed that the drug release rate from prepared microspheres was 89.2 ± 3.12 % to 96.88 ±2.44 % in 0.1 N HCl (pH 1.2) after 24 h. The drug release was found to occur through swelling process.
Figure 3:
In vitro drug release profiles from formulation F1-F8 (Data presents mean ± SD, n = 3).
From Table 3 , it can be seen that all the formulations had 'n' values greater than 0.5 and less than 1, which confirms that the release mechanism of venlafaxine HCl from the floating microspheres in acidic media (pH 1.2) was Fickian diffusion with swelling. 
Response surface plots
The relationship between the dependent and independent variables was further elucidated using response surface plots. Figure 4 shows that the percentage buoyancy of the microspheres decreased with an increase in the polymer concentration. This could be due to an increase in viscosity of the organic phase, which, in turn, increases the particle density. Figure 5 suggests that the polymer concentration have a significant effect on drug release and control the release of drug from the microspheres. The increased density of the polymer matrix at higher polymer concentration results in an increased diffusion path length, which may decrease the overall drug release from the polymer matrix. Also, smaller particles formed at lower polymer concentration exhibit larger surface area for exposure to the dissolution medium. The drug release pattern may be changed by appropriate selection of the polymers levels [18] [19] . 
CONCLUSION
The major limitation of gas generating floating system is that these systems cause alkaline micro envornment due to the presence of alkali salt. The prepared microspheres showed great potential in replacing the alkaline microenvironment created by gas-generating microspheres. It was found that the developed microspheres had ideal physical properties and drug release profiles to be used as controlled release microparticulate floating drug delivery system. Based on the results obtained from this study, it is hoped that further research with a variety of natural gum will lead to the development of more effective floating drug delivery systems.
MATERIALS AND METHODS
Materials
Venlafaxine HCl was received as gift sample from Torrent Pharmaceuticals, Ahmadabad. Ethyl cellulose and HPMC K100M were purchased from Fine Chem. Labs., Mumbai. Pullulan gum was received as gift sample from Aurobindo Pharmaceuticals Ltd., Hyderabad. Microcrystalline cellulose, sodium bicarbonate, liquid paraffin, Tween 80, petroleum ether, citric acid, hydrochloric acid, magnesium stearate, and talc were purchased from CDH (P) Ltd., Mumbai, India.
Methods
Preparation of venlafaxine HCl floating microspheres
Microspheres containing venlafaxine HCl were prepared using non-aqueous solvent evaporation method. Accurately weighed quantities of drug and polymers were dispersed in a solvent mixture containing dichloromethane and ethanol ( Table 4 ). The mixture was slowly introduced into 60 ml of light liquid paraffin containing Tween 80 as an emulsifier with continuous stirring using a precision digital stirrer (LT400A, Yamato, Japan). The temperature was maintained at 25C and stirring was continued for 2 h for complete evaporation of solvent. The microspheres were collected, washed repeatedly with petroleum ether and dried at room temperature (25C) until free flowing particles were obtained [9] [10] [11] . The percentage yield was calculated as the mass of the microspheres recovered from each batch divided by the total mass of drug and polymers used in the preparation of the particular batch.
Yield (%) =
Total mass of microspheres Total mass of drug and polymers X 100
Drug polymer compatibility study by Fourier transform infrared (FTIR) spectroscopy
The molecular interaction between drug and excipients was examined by FTIR spectroscopy using KBr disc (IR affinity-1, Shimadzu, Japan). The samples were triturated with dried KBr at a weight ratio of 1:100 and compacted into a disc using a KBr press at 10 tons for 2 min. The sample disc was placed in the sample holder and scanned from 4000 to 400 cm -1 at a resolution of 4 cm -1 .
Determination of particle size
The analysis of particle size was carried out using a photomicroscope (QUASMO, Quality Scientific, Ambala) fitted with micrometric tools (Winzoe). The particle size distribution was determined and the average diameter was calculated for each batch of microspheres. The analysis was done in triplicate for each batch.
Determination of bulk density and tapped density
Samples (1 g) were taken into a 10 ml graduated measuring cylinder separately and the volume was recorded. The graduated measuring cylinder was tapped 50 times using USP bulk density apparatus (ETD 1020, Electrolab, Mumbai, India). The analysis was done in triplicate for each batch. The bulk density and tapped density were determined using the following formula [12] :
Bulk density = Mass of floating microspheres Initial volume of microspheres Tapped density = Mass of floating microspheres Final volume of microspheres after tapping
Determination of angle of repose
For the determination of angle of repose, the microspheres were poured through a funnel, which was fixed at a position such that its lower tip was at a height of 2 cm above the surface. The microballoons were poured till the time when the tip of the microballoons pile surface touched the funnel. The tan -1 of ratio the height of the pile (h) and radius (r) of its base gave the angle of repose. The analysis was done in triplicate for each batch. The angle of repose was determined by following formula [12] :
Determination of Carr's index
The analysis was done in triplicate for each batch. The density determinations were used to determine the Carr's index by following formula [12] :
Hausner's ratio = Tapped density − Bulk density Tapped density
Determination of Hausner's ratio
The analysis was done in triplicate for each batch. The density determinations were used to determine the Hausner's ratio by following formula [12] :
Hausner's ratio = Tapped density Bulk density
Determination of percentage buoyancy
The analysis was done in triplicate for each batch. The microspheres were spread over the surface of USP Type II dissolution apparatus filled with 900 ml of HCl (1.2 pH) containing 0.01% w/v of Tween 80. The medium was agitated with a paddle rotating at 100 rpm for 12 h. The floating and the settled portions of microspheres were recovered, dried and weighed separately. Buoyancy percentage was calculated as the ratio of the mass of particles that remained floating and the total mass of the recovered microspheres.
Determination of percentage entrapment efficiency
The practical drug content was determined by UV analysis in triplicate for each batch. Entrapment efficiency was calculated using following formula [13] :
Drug entrapment efficiency (%) = Practical drug content Theoretical drug content X 100
Determination of surface morphology
The morphological characterization of floating microspheres was carried out by Scanning electron microscopy (Quanta FEI 200F). The dried microspheres were coated with gold foil (100 Å) under an argon atmosphere in a gold coating unit and micrographs were obtained at both higher and lower resolutions.
Determination of in-vitro drug release profiles
In vitro drug release studies were carried out at 37 o C for all batches using USP Type II dissolution test apparatus. Microspheres equivalent to 150 mg of the Venlafaxine HCl were used for the study. The dissolution studies were carried out using UV spectrophotometer ( UV 3000 + , Lab India, Mumbai.) at 223 nm using dissolution media (pH 1.2 HCl Buffer and SGF). Sample (5 ml) were withdrawn at predetermined time interval, diluted suitably and analyzed at 223 nm. Analysis was done in triplicate for each batch [14] .
Kinetics of drug release [15] : Zero order release kinetics refers to the process of constant drug release from a drug delivery device such as oral osmotic tablets, transdermal systems, matrix tablets with low-soluble drugs and other delivery systems.
where Q is the amount of drug released (assuming that release occurs rapidly after the drug dissolves), Q0 was the initial amount of drug in solution and K0 was the zero order release constant. A plot of the percent of drug released against time will be linear, if the release obeys zero-order kinetics. The value of release rate constant k0 was obtained in each case from the slope of cumulative percent drug released versus time plot. The first-order equation describes the release from systems where the rate was concentration dependent. Where Q0 was the initial amount of the drug, time 't' in minutes and k1 described the dissolution rate constant for first-order release kinetics. A plot of the logarithm of cumulative percent of drug remained against time would be linear if the drug obeyed first-order release kinetics.
Values of release rate constant kt were obtained in each case from the slope of the log cumulative percent of drug remained versus time plots.
A plot of the fraction of drug released against square root of time would be linear if the release obeyed Higuchi's equation.
where Q(t) is the percent of drug dissolved, time't' in minutes, kH is the dissolution rate constant for square root of time kinetics in percent drug dissolved. Values of release rate constant kH were obtained in each case from the slope of the cumulative percent of drug released versus square root of time plots.
Korsmeyer et al. (1983) derived a simple relationship which described drug release from a polymeric system. To find out the mechanism of drug release, first 60% drug release data were fitted in KorsmeyerPeppas' model.
Mt / M∞ = Kt n
where Mt / M∞ is a fraction of drug released at time t, k is the release rate constant and n is the release exponent. The n value is used to characterize different release for cylindrical shaped matrices. In this model, the value of n characterizes the release mechanism of drug. To study the release kinetics, the values of the release exponent (n) and the kinetic constant (k) were determined in each case from the slope and y-intercept of logarithmic plot of cumulative percent of the drug released versus time, respectively.
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